Design, Synthesis of Pyridine Based Thiazolidine Derivatives and Investigation of Antimicrobial Activity Targeting Ergosterol Biosynthesis via In Vitro and In Silico Approaches
Open Access
- 10 July 2026
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 108 (1) , e70356
Abstract
Pyridine and thiazolidine ring systems are unique heterocyclic rings since they are present in the structure of various drug/drug‐like molecules and reported in many studies for their distinct biological effects. It is of interest to pharmaceutical chemists because of their chemotherapeutic effect profiles such as antibacterial, antifungal, antiviral, and anticancer; briefly, their cytotoxic effects are very interesting. Because of these cytotoxic activities, in this project, we synthesized chalcone derivatives from the 5 th position of the thiazolidin‐4‐one and its linking pyridine by the hydrazone bridge. The antibacterial activities of the resulted compounds on different gram (+) and (−) bacteria and their antifungal activities tested against several invasive fungi. Due to significant fungistatic activity, the inhibitory activity on lanosterol demethylase (LDM, 5TZ1, CYP51A1) and aromatase (3EQM, CYP19A1) enzymes was evaluated, and in silico approaches were used to clarify and explain the binding modes, and then the structure activity relationship (SAR) was reported. Results of the study indicated that designed molecules were successfully obtained with important antifungal activity, and the mechanism of action was clarified.Keywords
Funding Information
- Bilecik Şeyh Edebali Üniversitesi (2023‐01.BŞEÜ.12‐04)
This publication has 59 references indexed in Scilit:
- The New Antibiotic Mantra—“Shorter Is Better”JAMA Internal Medicine, 2016
- Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activityEuropean Journal of Medicinal Chemistry, 2014
- Selective Antimicrobial Activity Associated with Sulfur NanoparticlesJournal of Biomedical Nanotechnology, 2011
- Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolonesJournal of Cataract & Refractive Surgery, 2009
- Control of cell selectivity of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPEThe Journal of Infectious Diseases, 2008
- A phase 1 trial of XK469: Toxicity profile of a selective topoisomerase IIβ inhibitorInvestigational New Drugs, 2006
- Pore formers promoted release of an antifungal drug from functionalized polyurethanes to inhibit Candida colonizationJournal of Applied Microbiology, 2006
- Short-course Empiric Antibiotic Therapy for Patients with Pulmonary Infiltrates in the Intensive Care UnitAmerican Journal of Respiratory and Critical Care Medicine, 2000